peoplePerson
Nathan A. Pennell
Lung cancer oncologist who has pushed for universal biomarker testing and better trial design.
Leads lung cancer clinical research at Cleveland Clinic; ASCO educational leader on molecular testing in NSCLC.
Role
Vice Chair of Clinical Research, Taussig Cancer Institute; Lung Cancer Medical Oncology Program
Institution
Specialisms
Lung cancerBiomarker testingClinical research operations
Profiles
| Title | Journal | Year |
|---|---|---|
| Biomarker testing for patients with advanced non-small cell lung cancer: real-world issues and tough choices | ASCO Educational Book | 2019 |